
Sign up to save your podcasts
Or


Europe has mostly been spared from the synthetic opioid crisis that has ravaged the U.S. over the past two decades. But now, a deadly new drug could be changing that: nitazenes. Up to 15 times stronger than fentanyl, nitazenes have been behind hundreds of overdose deaths in European countries over the past few years. WSJ's Sune Rasmussen on where the drug comes from and why it's doing so much damage. Jessica Mendoza hosts.
Further Listening:
Fentanyl Is Bad. ‘Tranq’ Might Be Worse.
The Push to Test Drugs for Fentanyl
Why Some Opioid Victims Are Challenging Purdue’s Settlement
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal & Spotify Studios4.2
55205,520 ratings
Europe has mostly been spared from the synthetic opioid crisis that has ravaged the U.S. over the past two decades. But now, a deadly new drug could be changing that: nitazenes. Up to 15 times stronger than fentanyl, nitazenes have been behind hundreds of overdose deaths in European countries over the past few years. WSJ's Sune Rasmussen on where the drug comes from and why it's doing so much damage. Jessica Mendoza hosts.
Further Listening:
Fentanyl Is Bad. ‘Tranq’ Might Be Worse.
The Push to Test Drugs for Fentanyl
Why Some Opioid Victims Are Challenging Purdue’s Settlement
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

30,626 Listeners

2,826 Listeners

1,714 Listeners

4,352 Listeners

1,634 Listeners

112,333 Listeners

673 Listeners

56,404 Listeners

1,449 Listeners

10,226 Listeners

5,444 Listeners

1,553 Listeners

15,942 Listeners

1,322 Listeners

613 Listeners

151 Listeners

145 Listeners